Table 2 Estimates of cancer incidence in Aboriginal males, NSW, 1999-2007, and risk comparison with non-Aboriginal males
From: Estimates of cancer incidence, mortality and survival in aboriginal people from NSW, Australia
Cancer site | Registered cases | Missing (%) | Imputed cases | Imputed incidence3 per 100,000 (95% CI) | SIR1(95% CI) | Risk2 to age 75, 1 in: | |
|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | Â | Â | Aboriginal | Non-Aboriginal |
Head and neck | 96 | 6.4 | 103 | 37.9 (28.5-47.2) | 2.05 (1.64-2.46) | 34 | 59 |
Oesophagus | 27 | 2.2 | 28 | 13.6 (7.5-19.7) | 1.85 (1.15-2.54) | 86 | 174 |
Stomach | 46 | 3.1 | 47 | 25.5 (16.7-34.3) | 1.85 (1.32-2.38) | 54 | 107 |
Large bowel | 147 | 6.4 | 158 | 75.4 (60.6-90.3) | 1.06 (0.88-1.23) | 17 | 17 |
Liver | 29 | 2.1 | 30 | 11.7 (6.9-16.6) | 1.67 (1.06-2.27) | 81 | 172 |
Pancreas | 32 | 1.1 | 32 | 17.7 (10.2-25.1) | 1.53 (1.00-2.06) | 87 | 124 |
Lung | 200 | 2.1 | 206 | 111.0 (92.6-129.4) | 1.93 (1.66-2.19) | 12 | 23 |
Melanoma of skin | 37 | 41.2 | 67 | 33.6 (21.3-45.9) | 0.44 (0.29-0.58) | 48 | 23 |
Mesothelioma | 11 | 1.7 | 11 | 7.4 (2.4-12.5) | 1.32 (0.54-2.10) | 211 | 276 |
Prostate | 183 | 20.0 | 239 | 144.5 (120.0-169.0) | 0.82 (0.71-0.94) | 10 | 8 |
Kidney | 50 | 9.1 | 53 | 24.1 (15.9-32.4) | 1.31 (0.95-1.66) | 60 | 73 |
Bladder | 30 | 5.3 | 31 | 23.3 (13.7-33.0) | 1.07 (0.69-1.45) | 105 | 87 |
Brain | 20 | 2.8 | 21 | 5.5 (2.2-8.8) | 0.74 (0.42-1.07) | 262 | 150 |
Non-Hodgkin’s lymphoma | 47 | 10.2 | 53 | 17.1 (11.4-22.7) | 0.95 (0.68-1.22) | 62 | 60 |
Multiple myeloma | 17 | 6.3 | 18 | 9.1 (3.9-14.2) | 1.24 (0.65-1.83) | 130 | 180 |
All leukaemias | 51 | 8.6 | 56 | 23.8 (15.0-32.5) | 1.06 (0.77-1.35) | 70 | 83 |
Unknown primary | 59 | 4.7 | 61 | 30.1 (20.7-39.5) | 1.63 (1.21-2.05) | 47 | 77 |
Myelodysplasia | 27 | 6.1 | 29 | 18.1 (9.7-26.4) | 1.50 (0.94-2.07) | 118 | 157 |
All cancers | 1,201 | 13.6 | 1,347 | 660.2 (613.7-706.6) | 1.09 (1.02-1.15) | 2.6 | 2.8 |